The Pharmaceutical Industry's Sino Speed Conundrum Pascal Soriot, CEO of AstraZeneca, has sounded the alarm about the western pharmaceutical industry's sluggish pace of innovation.
He warns that if companies don't adapt quickly, they risk being left behind by their Chinese counterparts.
But is this a case of China outpacing the west, or rather a matter of western companies failing to adjust to changing market conditions?